RBC Capital Downgrades Amrize to Underperform, Lowers Price Target to $48
RBC Capital analyst Anthony Codling downgrades Amrize (NYSE:AMRZ) from Sector Perform to Underperform and lowers the price target from $60 to $48.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga